DSCO
DoubleLine Securitized Credit ETF
Set alert
- YTD
- -2.50%
- 1 year
- -2.50%
- Open
- 24.53
- Prev close
- 24.38
- Mkt cap
- 136.36M
- Vol
- 13.01K
- Avg vol
- 51.36K
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 24.41
- High
- 24.48
News
4 months ago benzinga.com
ETF-ization Accelerates: SEC Share-Class Relief Puts Trillions In Mutual Fund Assets In Play
ETF conversions have surpassed 200 in the past 5 years. as SEC share-class relief opens new opportunities for mutual fund managers to expand into ETFs.
7 months ago benzinga.com
New DLUX ETF Targets Ultrashort Bonds Amid Interest Rate Volatility, Fed Pivot Debate
DLUX ETF offers an ultrashort bond strategy, aiming to deliver yield and stability as interest rate uncertainty and Fed policy risks keep markets on edge.
7 months ago etftrends.com
DoubleLine Expands Active ETF Suite With Ultrashort Income Strategy
DoubleLine has launched the DoubleLine Ultrashort Income ETF (DLUX), an active ETF designed to optimize returns while maintaining high liquidity and low interest-rate risk. Priced at 18 basis points,…
8 months ago benzinga.com
DoubleLine Converts Mutual Fund Into ETF — Here's Why It Matters For Bond Investors
DoubleLine has launched the DSCO ETF after converting its mutual fund, offering investors new access to securitized credit income beyond traditional bonds.
8 months ago etftrends.com
Mutual Fund to ETF Conversion Data Boosts Active Fixed Income ETF Case
Key trends like AI investing, geopolitical risk, and Fed narratives all dominate the market headlines. However, savvy investors know that sometimes, the big stories fly under the radar.
-
10 years ago benzinga.com
Earnings Scheduled For March 24, 2016
Earnings Scheduled For March 24, 2016
-
10 years ago benzinga.com
Discovery Labs Announces Beginning of AEROSURF Phase 2b Clinical Trial For Premature Infants 26-32 Weeks Old
Discovery Labs Announces Beginning of AEROSURF Phase 2b Clinical Trial For Premature Infants 26-32 Weeks Old
-
10 years ago benzinga.com
Results of AEROSURF Phase 2a Clinical Program in Premature Infants 29 to 34 Weeks Gestational Age Presented at the 2015 Hot Topics in Neonatology Annual Meeting-, Overall Safety And Tolerability Profile Of AEROSurf Group Comparable To Control Group
Results of AEROSURF Phase 2a Clinical Program in Premature Infants 29 to 34 Weeks Gestational Age Presented at the 2015 Hot Topics in Neonatology Annual Meeting-, Overall Safety And Tolerability Profile Of AEROSurf Group Comparable To Control Group
-
10 years ago benzinga.com
US Stock Futures Flat Ahead Of Jobless Claims
US Stock Futures Flat Ahead Of Jobless Claims
-
10 years ago benzinga.com
Discovery Labs Reports Encouraging Results for AEROSURF Phase 2a Clinical Program in Premature Infants 29-34 Weeks
Discovery Labs Reports Encouraging Results for AEROSURF Phase 2a Clinical Program in Premature Infants 29-34 Weeks
-
11 years ago benzinga.com
Earnings Scheduled For August 10, 2015
Earnings Scheduled For August 10, 2015
-
11 years ago benzinga.com
US Stock Futures Flat; All Eyes On Fed Minutes
US Stock Futures Flat; All Eyes On Fed Minutes
-
11 years ago benzinga.com
Discovery Labs Reports Enrollment of First Patient in AEROSURF Phase 2a Dose Expansion Trial
Discovery Labs Reports Enrollment of First Patient in AEROSURF Phase 2a Dose Expansion Trial
-
11 years ago benzinga.com
Discovery Labs Says Key Objectives of Phase 2a Clinical Trial of AEROSURF Were Achieved
Discovery Labs Says Key Objectives of Phase 2a Clinical Trial of AEROSURF Were Achieved
-
11 years ago benzinga.com
Earnings Scheduled For March 16, 2015
Earnings Scheduled For March 16, 2015
-
11 years ago benzinga.com
Discovery Laboratories Sees Mystery In Recent Stock Gyrations
Discovery Laboratories Sees Mystery In Recent Stock Gyrations
-
11 years ago benzinga.com
Earnings Scheduled For November 6, 2014
Earnings Scheduled For November 6, 2014
-
12 years ago benzinga.com
Discovery Labs Announces Organizational Change and Enhanced Expertise in Neonatology
Discovery Labs Announces Organizational Change and Enhanced Expertise in Neonatology
-
12 years ago benzinga.com
Discovery Labs Collaborates With Battelle on AEROSURF Program
Discovery Labs Collaborates With Battelle on AEROSURF Program
-
12 years ago benzinga.com
Discovery Laboratories, Inc. Reports Q2 EPS of $(0.14) vs $(0.15) Est
Discovery Laboratories, Inc. Reports Q2 EPS of $(0.14) vs $(0.15) Est
-
12 years ago benzinga.com
Discovery Laboratories, Inc. Reports Q1 EPS of $(0.14) vs $(0.13) Est
Discovery Laboratories, Inc. Reports Q1 EPS of $(0.14) vs $(0.13) Est
-
12 years ago benzinga.com
Revenues Decline at Discovery Labs in Q4, Shares Down - Analyst Blog
Revenues Decline at Discovery Labs in Q4, Shares Down - Analyst Blog
-
12 years ago benzinga.com
Discovery Laboratories, Inc. Reports Q4 EPS of $(0.16), Inline
Discovery Laboratories, Inc. Reports Q4 EPS of $(0.16), Inline
-
12 years ago benzinga.com
Earnings Scheduled For November 12, 2013
Earnings Scheduled For November 12, 2013
-
12 years ago benzinga.com
UPDATE: Piper Jaffray Initiates Coverage on Discovery Laboratories on Emerging Respiratory Franchise at Breathtaking Value
UPDATE: Piper Jaffray Initiates Coverage on Discovery Laboratories on Emerging Respiratory Franchise at Breathtaking Value
-
13 years ago benzinga.com
Discovery Labs Reports IND Submission for AEROSURF, Sees Neonatal Program Starting Q4
Discovery Labs Reports IND Submission for AEROSURF, Sees Neonatal Program Starting Q4
-
13 years ago benzinga.com
Discovery Labs Reports FDA Approval of SURFAXIN's Updated Specs
Discovery Labs Reports FDA Approval of SURFAXIN's Updated Specs
-
13 years ago benzinga.com
Discovery Laboratories, Inc. Reports Q2 EPS of $(0.22) vs $(0.28) Est
Discovery Laboratories, Inc. Reports Q2 EPS of $(0.22) vs $(0.28) Est
-
13 years ago benzinga.com
Discovery Labs Issues Final Assessment of Reintubation on Healthcare Costs, Says Infants Treated with Surfaxin Survival Higher without Intubation
Discovery Labs Issues Final Assessment of Reintubation on Healthcare Costs, Says Infants Treated with Surfaxin Survival Higher without Intubation
-
13 years ago benzinga.com
UPDATE: Discovery Labs Responds to FDA Request for Clarification of Recently Submitted SURFAXIN(R) (lucinactant) Updated Product Specifications
UPDATE: Discovery Labs Responds to FDA Request for Clarification of Recently Submitted SURFAXIN(R) (lucinactant) Updated Product Specifications
-
13 years ago benzinga.com
Discovery Laboratories, Inc. Reports Q1 EPS of $(0.29) vs $(0.26) Est
Discovery Laboratories, Inc. Reports Q1 EPS of $(0.29) vs $(0.26) Est
-
13 years ago benzinga.com
Discovery Laboratories, Inc. Reports Q4 EPS of $(0.16) vs $(0.28) Est
Discovery Laboratories, Inc. Reports Q4 EPS of $(0.16) vs $(0.28) Est
-
13 years ago benzinga.com
Earnings Scheduled For March 13, 2013
Earnings Scheduled For March 13, 2013
-
13 years ago benzinga.com
Benzinga's Small Cap Movers for Thursday February 14, 2013
Benzinga's Small Cap Movers for Thursday February 14, 2013
-
13 years ago benzinga.com
Shares of Discovery Labs Rally Sharply as Co. Receives $30M Funding Commitment from Deerfield
Shares of Discovery Labs Rally Sharply as Co. Receives $30M Funding Commitment from Deerfield
-
13 years ago benzinga.com
Discovery Labs Receives US Patent for Pulmonary Surfactant Formulations
Discovery Labs Receives US Patent for Pulmonary Surfactant Formulations
-
13 years ago benzinga.com
Discovery Labs Launches AFECTAIR for Infants
Discovery Labs Launches AFECTAIR for Infants
-
13 years ago benzinga.com
Discovery Labs Offers Data Showing Lower Rate of Reintubation Observed with SURFAXIN Treatment
Discovery Labs Offers Data Showing Lower Rate of Reintubation Observed with SURFAXIN Treatment
-
14 years ago benzinga.com
Discovery Labs Provides Commercial Update for SURFAXIN and AFECTAIR: Method to Assess Conformance Needs Improvment
Discovery Labs Provides Commercial Update for SURFAXIN and AFECTAIR: Method to Assess Conformance Needs Improvment
-
14 years ago benzinga.com
Discovery Labs Provides Commercial Update for SURFAXIN, AFECTAIR
Discovery Labs Provides Commercial Update for SURFAXIN, AFECTAIR
-
14 years ago benzinga.com
UPDATE: Stifel Nicolaus Initiates Discovery Laboratories at Buy with $5 PT
UPDATE: Stifel Nicolaus Initiates Discovery Laboratories at Buy with $5 PT